The increasing global population and intensifying resource limitations present a formidable challenge for sustainable crop production, especially in developing regions. This review explores the pivotal role of microbial ecosystem services in alleviating environmental stresses that impede agricultural productivity. Soil microbiota, particularly plant growth-promoting microbes (PGPMs), are integral to soil health and fertility and plant resilience against both abiotic (drought, salinity, temperature extremes, heavy metals) and biotic (pathogen) stresses. These microorganisms employ a variety of direct and indirect mechanisms, including the modulation of phytohormones, nutrient solubilization, the production of stress-alleviating enzymes, and the synthesis of antimicrobial compounds, to enhance plant growth and mitigate adverse environmental impacts. Advances in microbial biotechnology have expanded the toolkit for harnessing beneficial microbes, enabling the development of microbial inoculants and consortia tailored for specific stress conditions. This review highlights the multifaceted contributions of soil microbes, such as improving nutrient uptake, promoting root development, facilitating pollutant degradation, and supporting carbon sequestration, all of which underpin ecosystem resilience and sustainable agricultural practices. Furthermore, the synergistic interactions between plant roots and rhizospheric microbes are emphasized as key drivers of soil structure enhancement and long-term productivity. By synthesizing current research on the mechanisms of microbe-mediated stress tolerance, this review underscores the potential of microbial interventions to bridge the gap between food security and environmental conservation. The integration of microbial solutions into agroecosystems offers a promising, eco-friendly strategy to revitalize soils, boost crop yields, and ensure agricultural sustainability in the face of mounting environmental challenges.

Allogeneic stem cell transplantation (allo-SCT) improves the treatment of hematopoietic cancer and non-malignant disease. In this case, stem cells from a genetically similar but not identical donor may stimulate immune-mediated tumor cell destruction. Allogeneic stem cell transplantation, or allo-SCT, has significantly extended the life expectancy of numerous people. Nevertheless, complications such as infections, graft-versus-host disease (GVHD), and recurrence continue. This paper provides a thorough analysis of the possibility of allo-SCT. Advancements in allo-SCT have recently enhanced outcomes and diminished the adverse effects and mortality associated with treatment. The number of potential donors for allogeneic stem cell transplantation has grown due to the utilization of haploidentical and umbilical cord blood transplantation. One strategy to improve overall survival and decrease the occurrence of GVHD is to use T-cell depletion in conjunction with cyclophosphamide administration following transplantation. The goal of studying allo-SCT is to increase the graft-versus-tumor effects with few side effects. To enhance the body's natural mechanisms for combating tumors, researchers are investigating checkpoint inhibitors and CAR T-cell therapy. Manipulating genes and using precision medicine techniques could improve the process of selecting donors and decrease the occurrence of GVHD. This study proposes that allo-SCT could benefit non-malignant conditions such as autoimmune and metabolic disorders. The therapeutic efficacy may be enhanced by combining allo-SCT with innovative targeted and immunomodulatory medications. allo-SCT is being enhanced to enhance safety and expand its applicability to other diseases. Recent advances may improve patient outcomes and establish allo-SCT as a successful hematological and related treatment.

COVID-19 has presented considerable health hazards, particularly for immunocompromised persons, such as kidney transplant recipients. This population experiences increased susceptibility due to the immunosuppressive treatments necessary to avert organ rejection, potentially resulting in a diminished immune response to immunizations. The implementation of COVID-19 vaccinations has been essential in alleviating these dangers. Studies demonstrate differing levels of vaccine efficacy among kidney transplant recipients, underscoring the necessity for customized vaccination approaches. This assessment appraises the safety, effectiveness, and immunological responses of COVID-19 vaccinations in kidney transplant recipients, highlighting the significance of educated vaccination policies. Comprehending these processes is crucial for enhancing COVID-19 protection in this high-risk population and guiding continuous public health initiatives.

Introduction: Ovarian cancer remains one of the most prevalent and lethal gynecological malignancies globally, necessitating the exploration of novel therapeutic agents. Baicalein, a naturally occurring flavonoid, possesses potent antioxidant and anti-inflammatory properties and has recently gained attention for its anticancer potential. This study aimed to elucidate the anticancer efficacy and underlying molecular mechanisms of baicalein in human ovarian carcinoma PA-1 cells through comprehensive in vitro and in silico approaches. Methods: PA-1 cells were exposed to increasing concentrations of baicalein, and cytotoxicity was assessed using the MTT assay. Apoptotic induction was evaluated by measuring mitochondrial membrane potential (MMP), reactive oxygen species (ROS) induction, and nuclear morphological changes using DAPI, Hoechst/PI, and AO/EB staining. Cell cycle checkpoints were analyzed by flow cytometry. Apoptosis-related genes (p53, Bax, Puma, Noxa, and Bcl-2) expression was quantified using qRT-PCR. In silico molecular docking was performed using PyRx to predict interactions with key apoptotic proteins, while SwissADME was employed to assess pharmacokinetic properties and drug-likeness. Results: Baicalein significantly reduced PA-1 cell viability in a concentration-dependent manner and induced pronounced morphological changes characteristic of apoptosis. Treatment resulted in elevated ROS production, loss of MMP, nuclear condensation, and S-phase cell cycle arrest. Gene expression analysis demonstrated significant upregulation of pro-apoptotic markers (p53, Bax, Puma, and Noxa) alongside decreased expression of the anti-apoptotic gene Bcl-2. Molecular docking studies revealed favorable binding affinities of baicalein with apoptosis-regulating proteins, and SwissADME analysis confirmed acceptable drug-likeness and pharmacokinetic profiles. Discussion: These findings showed that baicalein induces apoptosis in ovarian cancer PA-1 cells via a ROSmediated, mitochondria-dependent pathway. Conclusion: This study highlights the potential of baicalein as a promising lead compound for the development of anticancer therapeutics.

Plant fragrance is the blend of volatile terpenoids, phenylpropanoids/benzenoids, fatty acid derivatives, and nitrogen- or sulfur-containing compounds released from flowers, leaves, and fruit. It drives pollination and defence and accounts for much of the economic value of aromatic, medicinal, and ornamental crops. However, it shifts with genotype, developmental stage, tissue type, and stress, and a large share of it still comes from wild-harvested plants. Endophytic bacteria are the microorganisms that colonize internal plant tissues without causing apparent disease symptoms, may modulate these specialized metabolic pathways. Only a limited number of studies have directly investigated these interactions. In contrast, a substantially larger body of research has demonstrated the roles of endophytic bacteria in promoting plant growth and enhancing plant tolerance to environmental stresses. However, direct evidence establishing links between bacterial endophytes, specific genes within volatile-biosynthetic pathways, and the volatile compounds actually released by plants remains limited. The current review summarizes the current evidence on the regulation of major plant volatile biosynthetic routes by endophytic bacteria, including the MVA and MEP pathways for terpenoids, the shikimate-derived phenylpropanoid/benzenoid pathway, as well as the lipoxygenase pathway leading to green-leaf volatile production. The suggested mechanisms are generally grouped into several inter-related categories, such as microbial elicitation and pattern recognition, phytohormonal reprogramming, nutrient and precursor acquisition, modulation of carbon flux through the MVA/MEP and phenylpropanoid pathways, redox regulation and stress priming, and bacterial volatile-mediated signalling. More speculative mechanisms are discussed separately, such as microbial biotransformation, direct microbial biosynthesis of plant volatiles, and horizontal gene transfer. Evidence from culinary and essential oil herbs, medicinal plants, ornamental flowers, and fruit crops is evaluated using an evidence hierarchy that distinguishes phenotypic associations from experimentally validated causal mechanisms. Establishing a robust gene-to-metabolite causal framework will require targeted approaches, including gnotobiotic inoculation, volatilomic profiling, and stable-isotope tracing.

Background: Salvadora persica (S. persica), commonly known as ‘Miswak,’ has been used in ethnotraditional applications since ancient times. This study was formulated to examine bioactive phenolics and flavonoids from the hydroethanolic extract of S. persica bark, anticancer activity, and in silico binding interaction analysis with key therapeutic targets of triple-negative breast cancer (TNBC) cells. Methods: UHPLC was used to identify the phytochemicals in S. persica bark extract. Cell death was analyzed by MTT assay in TNBC MDA-MB-231 and MDA-MB-468 cells. Moreover, cellular apoptosis, ROS generation, MMP, and cell cycle checkpoints were also carried out. AutoDock Tools 1.5.7 and PyRx 0.8 tools were used for molecular binding interaction analysis. Results: Phytochemical analysis revealed the presence of total phenolic and total flavonoid content of 26.90 ± 0.46 μg GAE/mg and 54.51 ± 0.42 μg QE/mg of bark extract, respectively. UHPLC analysis confirmed the presence of fumaric acid, chlorogenic acid, rutin, and quercetin in the extract. S. persica significantly reduced cell viability of MDA-MB-231 and MDA-MB-468 cells with an IC₅₀ value of 144 and 128 μg/mL, respectively. S. persica extract elevated ROS generation, loss of MMP, late apoptosis induction, and G2/M-phase cell cycle arrest, while it did not show any significant effect against normal kidney Vero cells. Molecular docking studies revealed that rutin showed strong binding affinity towards EGFR with B.E. = −9.8 and −9.5 Kcal/mol; FGFR1 with B.E. = −7.4 and −7.5 Kcal/mol; FGFR4 with B.E. = −7.5 and −7.9 Kcal/mol; and csGRP78 with B.E. = −9.0 and −9.3 Kcal/mol, using Autodock Vina and PyRx tools, respectively. SwissADME and drug-likeness analysis confirmed acceptable drug-like characteristics and favorable pharmacokinetic profiles of the identified molecules. Conclusions: This study highlighted the potential of phytochemicals from S. persica bark as promising compounds for the development of novel anticancer therapeutics.